DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Besareb A, Flaharty KK, Erslev AJ, McCrea JB, Vlasses PH, Medina F.
Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease: the case for subcutaneous administration.
J Am Soc Nephrol 1992; 2: 1405-1416
We do not assume any responsibility for the contents of the web pages of other providers.